Bharat Biotech's Covaxin likely to get clearance for phase 3 data from DCGI today: Sources

Bharat Biotech's Covaxin is likely to get clearance from Drugs Controller General of India (DCGI) today, sources said on Tuesday.

(To receive our E-paper on whatsapp daily, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

Free Press Journal